Tecncicals broken down.
Flu is sparse.
Relenza 'appears to have been sold cheap'
LANI may not compete with cheap relenza
LANI may not provide the capital hoped
SP = ??
however.. gsk may drive up relenza given big downturn in vaccines.
GSK has 'most likely' held invoices until 10/11
Japanese hopefully hold the key to LANI deal.
pandemics / swine / bird remain unknown are real.
bta takeover very possible, page-56
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)